医疗三角公司2025年季度报告

Large accelerated filer☐Accelerated filer☐Non-accelerated filer☒Smaller reportingcompany☒Emerging growthcompany☒ complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes☐No☒ Unaudited Condensed Consolidated Balance sheetsUnaudited Condensed Consolidated Statements of OperationsUnaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) PART II - OTHER INFORMATIONItem 1. Legal Proceedings Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, involving substantial risksand uncertainties. The words “believe,” “may,” “will,” “potentially,” “plan,” “could,” “should,” “predict,” “ongoing,” “estimate,”“continue,” “anticipate,” “intend,” “project,” “expect,” “seek,” or the negative of these words, or terms or similar expressionsconveying uncertainty of future events or outcomes, or that concern our expectations, strategy, plans or intentions, are intended to mind the risk factors and other cautionary statements discussed under the heading “Risk Factors” and in our publicly available filingsand press releases. These statements include, among other things, those regarding:●our ability to continue to add new customers and increase sales to our existing customers;●our ability to develop new solutions and bring them to market in a timely manner;●our ability to timely and effectively scale and adapt our existing solutions;●our dependence on establishing and maintaining a strong brand; ●economic and industry trends or trend analysis; ●anticipated income tax rates, tax estimates and tax standards; ●interest rate changes; ●the future trading prices of our common stock; ●our expectations regarding the outcome of any regulatory investigation or litigation; ●the amount and timing of future repurchases of our common stock under any share repurchase program; ●the potential impact of shareholder activism on our business and operations; ●the length and severity of the coronavirus (COVID-19) pandemic and its impact on our business, customers and employees; as well as other statements regarding our future operations, financial condition, growth prospects and business strategies. We operate in very competitive and rapidly-changing environments, and new risks emerge from time-to-time. It is not possible for usto predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination offactors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of You should not rely upon forward-looking statements as predictions of future events. Although we believe the expectations reflected inour forward looking statements are reasonable, we cannot guarantee the future results, levels of activity, performance or events andcircumstances described in the forward looking statements will be achieved or occur. Neither we, nor any other person, assume forward-looking statements.Unless expressly indicated or the context suggests otherwise, references to “Healthcare Triangle,” “company,” “we,” “us” and “our”refer to Healthcare Triangle Inc. and its consolidated subsidiary. Balance at December 31, 20236,000$--$-4,308,822-$26,211$ Preferential Issue----417,395 1) Organization and Description of Business converted into a Delaware corporation on April 24, 2020, to provide IT and data services to the Healthcare and Life Sciences(‘HCLS”) industry. On January 1, 2020, the Company acquired the Life Sciences Business of SecureKloud Technologies Inc. (“Parent”) and on May 8, 2020, the Company acquired Cornerstone Advisors Group LLC (Healthcare Business) from its Parent.Company reinforces healthcare progress through breakthrough technology and extensive industry know-how. Company support healthcare providers and payors, hospitals and pharma/life sciences organizationsin their effort to improve health outcomes byenabling the adoption of new technologies, data enlightenment, business agility andaccelerate responding to immediate businessneeds and competitive threats. Thehighly regulatedHCLS industry turn to Company for expertise in digital transformation on the Company concentrates on accelerating value to the three healthcare sectors: infrastructure to advance the clinical trial process to drug discovery and delivery. As an organization with the deep-rooted cloud expertise, Company’s technology significantly relies on Big Data, Analytics, DevOps, 2) Summary of Significant Accounting PoliciesBasis of consolidated financial statementsThe accompanying condensed consolidated financial statements include the accounts of Healthcare Triangle, Inc and Devcool, Inc itswholly owned subsidiary. The condensed consolidated financial statements have been prepared in accordance with